Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06439160
Other study ID # 49C401
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date January 10, 2024
Est. completion date December 31, 2026

Study information

Verified date June 2024
Source Istituto Auxologico Italiano
Contact Federico Brusa, Ph.D
Phone +393517797622
Email f.brusa@auxologico.it
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Anorexia Nervosa (AN) is an eating disorder often characterised by restriction of food intake, being underweight, body image uneasiness, and the possibility of binge eating, purging, fasting behaviours, and excessive exercising. Despite weight and eating habits being one, and perhaps the most recognizable, components of AN, AN is a multidimensional disease. For example, individuals affected by AN might show psychological suffering, such as depression and anxiety. For example, social anxiety disorder/social phobia is the first or second most common comorbid anxiety in AN (i.e. prevalence rates ranging from 16% to 88.2% in AN against 12% in the general population). Moreover, the highest the level of social anxiety the highest the severity of the eating disorder psychopathology. This latter component resonates with findings on the difficulties observed in people affected by AN in creating and maintaining satisfactory relationships with others. These evidences tell us the importance to take into account the social components/skills of people affected by AN. The development of social components/skills of people affected by AN during their recovery can be considered as a protective factor for future relapse. This would be of relevance for the creation of rehabilitative programs.


Description:

Anorexia Nervosa (AN) is an eating disorder often characterised by restriction of food intake, being underweight, body image uneasiness, and the possibility of binge eating, purging, fasting behaviours, and excessive exercising. AN is of relevance for the health care system because of the high mortality rates, high psychiatric comorbidity, high suicide risk, and because of the high costs for the health system. Despite weight and eating habits being one, and perhaps the most recognizable, components of AN, AN is a multidimensional disease. For example, individuals affected by AN might show psychological suffering, such as depression and anxiety. For example, social anxiety disorder/social phobia is the first or second most common comorbid anxiety in AN (i.e. prevalence rates ranging from 16% to 88.2% in AN against 12% in the general population). Moreover, the highest the level of social anxiety the highest the severity of the eating disorder psychopathology. This latter component resonates with findings on the difficulties observed in people affected by AN in creating and maintaining satisfactory relationships with others. These evidences tell us the importance to take into account the social components/skills of people affected by AN. Therefore, we believe it would be relevant to understand whether our treatments change the social components/skills of the people affected by AN who access our ward's multidisciplinary inpatient intensive rehabilitation treatment. Moreover, it would be important to evaluate the protective role of participants' social components/skills in the changes in their psychopathology. Despite our rehabilitative activities not having a specific focus on sociality, the activities are conducted on a 1:1 or group basis. This means that our activities have an intrinsic relational and socializing value. The purpose of the study lays on two outcomes: - Primary outcome: evaluation of the short-term effects (T0 vs T1) of the multidisciplinary inpatient intensive rehabilitation treatment on the social components/skills of people affected by AN. - Secondary outcome: evaluation of the long-term effects (T0 vs T2) of the multidisciplinary inpatient intensive rehabilitation treatment on the social components/skills of people affected by AN. The development of social components/skills of people affected by AN during their recovery can be considered as a protective factor for future relapse. This would be of relevance for the creation of rehabilitative programs


Recruitment information / eligibility

Status Recruiting
Enrollment 45
Est. completion date December 31, 2026
Est. primary completion date January 10, 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - age between 18 and 65 years old; - diagnosis of AN, as per DSM V criteria (APA, 2013); - BMI = 17 Kg/m2; - adherence to the rehabilitation program, meaning participating at the 75% of the proposed activities. Exclusion criteria: - presence of other pathologies not associated with AN (i.e., neurodegenerative diseases); - severe psychopathologies other than AN (i.e., schizophrenia); - spontaneous dropout from the multidisciplinary inpatient intensive rehabilitation treatment.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Participants will be asked to complete a series of questionnaires at t0, t1 and t2
Individuals will be people who voluntarily will take part in a residential three to six weeks multidisciplinary inpatient intensive rehabilitation treatment targeting the improvement of psychological well-being, body image, and psychopathology for anorexia nervosa. Therefore, at T0 (at the beginning of the treatment) and T1 (at the end of the rehabilitation programme), participants will fill out some self-report questionnaires to evaluate the effect of the multidisciplinary inpatient intensive rehabilitation treatment on different outcomes (i.e. psychological well-being, eating pathology, body image, and comorbidities), among which their social components/skills. Moreover, we will ask participants to complete 3 months after discharge the questionnaires related to the social components/skills only. Participants will be contacted by email, within the email participants will find a link to click on for the completion of the questionnaires.

Locations

Country Name City State
Italy istituto Auxologico italiano IRCSS Milano MI

Sponsors (3)

Lead Sponsor Collaborator
Istituto Auxologico Italiano Catholic University of the Sacred Heart, University of Turin, Italy

Country where clinical trial is conducted

Italy, 

Outcome

Type Measure Description Time frame Safety issue
Primary Anticipatory and Consummatory Interpersonal Pleasure Scale (ACIPS) Social anhedonia will be evaluated by the Anticipatory and Consummatory Interpersonal Pleasure Scale (ACIPS). This self-report questionnaire is made up of 17-item for measuring individuals' tendency to look forward to interactions with others (anticipatory interpersonal pleasure - 7 items) and the experienced pleasure in social interactions (consummatory interpersonal pleasure - 10 items). The ACIPS is scored on a six-point Likert scale ranging from 1 (very false for me) to 6 (very true for me). Through study completion, an average of 4 months
Primary The Social Appearance Anxiety Scale (SAAS) The scale will be used to assess anxiety about being negatively evaluated by others because of one's overall appearance, including body shape (e.g., "I am concerned people would not like me because of the way I look and I am afraid that people find me unattractive"). The scale contains 16 items rated on a 5-points Likert scale ranging from 1 = not at all to 5 = extremely, with higher scores reflecting a higher social appearance anxiety scale. Through study completion, an average of 4 months
Primary The Social Interaction Anxiety Scale (SIAS) The scale will be used to assess the fear of interacting in dyads and groups (e.g., ''I have difficulty talking with other people''). The scale contains 20 items rated on a 5-points Likert scale ranging from 0 = not at all to 4 = extremely, with a higher score indicating greater social interaction anxiety Through study completion, an average of 4 months
Primary Social Phobia Scale (SPS) We will administer the scale to evaluate the fear of being scrutinized by others during routine activities, such as eating, drinking, or writing (e.g., ''I become anxious if I have to write in front of other people''). The scale is made up of 20 items rated on a five-points Likert scale ranging from 0 = not at all to 4 = extremely, with a higher score indicating greater fear of scrutiny. Through study completion, an average of 4 months
See also
  Status Clinical Trial Phase
Recruiting NCT05531604 - Appetitive Conditioning in Anorexia Nervosa
Enrolling by invitation NCT04174703 - Preparing for Eating Disorders Treatment Through Compassionate Letter-Writing N/A
Active, not recruiting NCT04883554 - Impact of an Olfactory Sensory Therapeutic Group for Adolescent Patients With Restrictive Anorexia Nervosa , Pilot Study N/A
Recruiting NCT04213820 - TMS and Body Image Treatment for Anorexia Nervosa N/A
Completed NCT03414112 - The Impact of Oxytocin on the Neurobiology of Anorexia Nervosa Early Phase 1
Recruiting NCT06144905 - Norwegian Microbiota Study in Anorexia Nervosa
Recruiting NCT05803707 - Home-based Adapted Physical Activity in Anorexia Nervosa: a Feasibility Pilot Study N/A
Recruiting NCT05682417 - Impact of Body Schema Distortion on Remission and Weight Regain in Anorexia Nervosa N/A
Not yet recruiting NCT06380257 - Anorexia Nervosa and Brain in Adolescence
Not yet recruiting NCT04804800 - Virtual Reality Place in the Management of Body Dysmorphia Disorders in Anorexia Nervosa N/A
Not yet recruiting NCT03600610 - Evaluation of CARdiac Abnormalities by Echocardiography and MRI in Malnourished Patients Suffering From Anorexia Nervosa N/A
Completed NCT02745067 - Effectiveness of Enhanced Cognitive Behavioral Therapy (CBT-E) in the Treatment of Anorexia Nervosa N/A
Completed NCT02382055 - Changing Habits in Anorexia Nervosa: Novel Treatment Development N/A
Completed NCT03075371 - Homeostatic and Non-homeostatic Processing of Food Cues in Anorexia Nervosa N/A
Terminated NCT02240797 - Kappa Opioid Receptor Imaging in Anorexia N/A
Completed NCT03144986 - Insula-coil Deep TMS for Treatment Resistant Anorexia Nervosa N/A
Unknown status NCT01761942 - Fatty Acids Omega -3 Diet Supplementation Efficiency and Safety Evaluation in Anorexia Nervosa Phase 2
Completed NCT02551445 - A fMRI Pilot Study of the Effects of Meal-support in Eating Disorders. N/A
Completed NCT01579682 - Adaptive Family Treatment for Adolescent Anorexia Nervosa N/A
Completed NCT00946816 - The Effects of Dietary Intervention on Gastrointestinal Function in Patients With Anorexia Nervosa and Obesity N/A